(Q54243883)
Statements
[Oral combination chemotherapy with capecitabine and cyclophosphamide in combination with endocrine therapy and anti-HER2 therapy for advanced and metastatic breast cancer]. (English)
1 reference
Ryuji Okamura
1 reference
Tatsushi Kato
1 reference
Ritsuko Sata
1 reference
1 September 2012
1 reference
1 reference
70 Suppl 7
1 reference
592-596
1 reference
Identifiers
1 reference